OP Asset Management Ltd Invests $1.60 Million in HealthEquity, Inc. $HQY

OP Asset Management Ltd acquired a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY) during the first quarter, HoldingsChannel.com reports. The institutional investor acquired 19,105 shares of the company’s stock, valued at approximately $1,597,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Sivia Capital Partners LLC purchased a new stake in shares of HealthEquity during the second quarter valued at about $306,000. Arrowstreet Capital Limited Partnership bought a new stake in shares of HealthEquity in the 2nd quarter valued at about $4,747,000. Marshall Wace LLP purchased a new position in shares of HealthEquity in the 2nd quarter worth approximately $5,483,000. Amundi grew its position in shares of HealthEquity by 9.3% in the 2nd quarter. Amundi now owns 30,203 shares of the company’s stock worth $3,059,000 after buying an additional 2,574 shares during the last quarter. Finally, Jump Financial LLC bought a new position in shares of HealthEquity during the 2nd quarter worth approximately $449,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Performance

HQY opened at $88.46 on Monday. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $106.60. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. The company has a market cap of $7.40 billion, a P/E ratio of 33.13, a price-to-earnings-growth ratio of 1.49 and a beta of 0.21. The firm’s 50-day moving average price is $85.30 and its 200-day moving average price is $84.72.

HealthEquity (NASDAQ:HQY) last released its earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. The company had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. HealthEquity’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, equities analysts anticipate that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

Analysts Set New Price Targets

HQY has been the subject of a number of analyst reports. Citizens Jmp increased their target price on shares of HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a research report on Monday, June 1st. Royal Bank Of Canada lifted their price target on shares of HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a report on Wednesday, June 3rd. Barrington Research reaffirmed an “outperform” rating and set a $110.00 price target on shares of HealthEquity in a research report on Friday, May 22nd. Weiss Ratings upgraded HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, June 5th. Finally, KeyCorp reiterated an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $110.57.

Insiders Place Their Bets

In other news, Director Gayle Furgurson Wellborn sold 2,439 shares of HealthEquity stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $219,510.00. Following the completion of the sale, the director directly owned 19,733 shares in the company, valued at approximately $1,775,970. The trade was a 11.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the business’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $675,000.00. Following the sale, the executive vice president directly owned 91,141 shares in the company, valued at $8,202,690. This trade represents a 7.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 13,081 shares of company stock valued at $1,193,000. Insiders own 1.60% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.